Ponsus Pharma develops high performing Dermatological products based on patented Proderm Technology® for pharmaceutical and cosmeceutical companies targeting the Fast Moving Consumer Goods market.
| Website | http://www.ponsus.com |
| Revenue | $3.2 million |
| Employees | 1 (0 on RocketReach) |
| Founded | 1994 |
| Address | Brovagen 9, Stocksund, Stockholm 18221, SE |
| Industry | Pharmaceuticals, Drug Manufacturing & Research, Healthcare |
| Keywords | Dermatological Products, Advanced Skincare, Innovative Skincare, Skincare, Cosmeceutical Products, Skin Health, Active Ingredients, Scientific Skincare, Pharmaceutical Ingredients, Patented Technology, Personal Care, Cosmetic Ingredients, Dermatology Research, Pharmaceutical Development, Cosmetic Formulations, Fast Moving Consumer Goods, Beauty Products, Consumer Goods |
| Competitors | Amgen, Bristol Myers Squibb, Gilead Sciences, Regeneron, Vertex Pharmaceuticals, AbbVie, Sanofi, Lilly India, Novartis, Pfizer +47 more (view full list) |
| SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Ponsus Pharma employee's phone or email?
The Ponsus Pharma annual revenue was $3.2 million in 2026.
Ponsus Pharma is based in Stocksund, Stockholm.
The NAICS codes for Ponsus Pharma are [32541, 3254, 325, 32].
The SIC codes for Ponsus Pharma are [2834, 28, 283].